lung metastases - search results
If you're not happy with the results, please do another search
Clinical trial continuation announced for robot-assisted treatment for lung metastases
Quantum Surgical announces the ongoing clinical trial for the treatment of lung metastases assisted by the Epione robot.
The study is coordinated by Thierry...
Percutaneous microwave and cryoablation suitable for sarcoma lung metastases treatment
Percutaneous microwave and cryoablation allow for repeat minimally invasive treatment of sarcoma lung metastases with mild complications, according to the conclusions of a study...
SOLSTICE preliminary data show cryoablation has “acceptable safety profile” in treatment of selected lung...
The SOLSTICE clinical study constitutes the largest multicentre, prospective study focused on the clinical use and effectiveness of cryotherapies for patients with primary cancer...
Lung ablation of metastases likely to become a first-line therapy for selected patients
The criteria for first-line therapy are an effective treatment that reproducibly delivers the required endpoint within the limits of acceptable toxicity, and crucially better than any of the other therapeutic options, writes Alice Gillams.
Ablation likely to play major role in treating breast cancer metastases
A study from France presented at the European Congress of Radiology (ECR, 4‰ÛÒ8 March, Vienna, Austria) has found that percutaneous thermal ablation is safe and effective for local control of metastatic breast cancer.
Selective transarterial chemo embolization in lung cancer
Embolization therapy combined with infusion of antineoplastic agents offers considerable improvement of symptoms for patients, with far fewer complications than systemic chemotherapy, writes Shinichi Hori, Osaka, Japan.
Evaluation of transpulmonary chemoembolization (TPCE)
The incidence of lung cancer has increased considerably in the last few decades with the lung as the most common site of metastatic involvement....
Interventional News’ top 10 most popular stories of April 2023
Several of Interventional News’ most read stories from April covered the topic of interventional oncology (IO)—its interrelation with immuno-oncology, a robot-assisted lung metastases treatment,...
SIO 2022: ‘Controversies’ in current cancer treatment
One of the sessions at this year’s Society of Interventional Oncology (SIO) meeting (24–28 March, San Francisco, USA) comprised four debates moderated by David...
Stephen B Solomon
Stephen B Solomon, chief, Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, New York, USA and president of the Society for Interventional Oncology (SIO)...
BTG to acquire Galil Medical
BTG has entered into an agreement to acquire Galil Medical, a provider of cryoablation products for the treatment and palliative care of kidney and other cancers.
Boston Scientific receives 510(k) clearance for expanded cryoablation system
Boston Scientific has received 510(k) clearance for expanded indication of the Visual Ice cryoablation system. The clearance grants this device an indication expansion to...
IO beyond interventional oncology: Progress in immuno-oncology
Recent advances in immuno-oncology are transforming the practice of medical oncology. Currently, antibodies directed against negative regulators of T-cell function, the so-called checkpoint inhibitors,...
“An important pillar of tumour treatment”: Degradable starch microspheres accepted by European guidelines
This advertorial is sponsored by PharmaCept.
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) recently incorporated transarterial chemoembolization with degradable starch microspheres (DSM-TACE) into...
Authors receive accolade of ‘Abstract of the Year’ at SIR 2022
At the Society of Interventional Radiology (SIR) 2022 Annual Meeting (11-16 June, Boston, USA), four of the abstracts submitted were declared ‘Abstract of the...
Laura Crocetti
“I think the future success of ablation was truly unforeseeable, in 1986, when Tito Livraghi published his first paper about ethanol injection in a...
New consensus guidelines will facilitate interventional oncology research
We are facing several problems in the field of clinical oncology research, by which I mean that study results are being collected, analysed and...
Interventional News’ top 10 most popular stories for June 2021
June 2021 saw the publication of issue 82 of Interventional News, and both our cover stories were amongst those most widely-read on our site...
Degradable starch microspheres offer greater flexibility with TACE, enabling whole-liver embolization
This advertorial is sponsored by PharmaCept.
Andreas H Mahnken (Clinic of Diagnostic and Interventional Radiology, Marburg University, Marburg, Germany) enthuses to Interventional News about the...
Ablation-confirmation software must become the new normal for IRs to be competitive with surgeons
“If interventional radiologists wish to become competitive with surgeons, the availability of software enabling the accurate comparison of pre- and post-interventional CT or...
Ablation 2.0: Improved precision as interventionalists approach A0
Ablation is entering a new era of increased precision and quantification, the interventional radiology (IR) community argues, with outcomes that match or surpass those...
NCCN incorporates SIO recommendations in 2020 guidelines for neuroendocrine tumour treatment
The Society of Interventional Oncology (SIO) National Comprehensive Cancer Network (NCCN) Task Force submitted recommendations to the NCCN for the latest revision of the...
Combining targeted Holmium-166 radioembolization with systemic therapy improves response rates in bulky liver disease...
This article is sponsored by Terumo.
The first prospective study on the combination of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and Holmium-166 (166Ho) radioembolization...
Society of Interventional Oncology requests updates to NCCN guidelines to more strongly recommend ablation
The Society of Interventional Oncology (SIO) is working more closely within cooperative groups and taskforces, as well as amongst the guidelines commentariat, to provide...
Biopsy alternative: ‘Wearable’ device captures cancer cells from blood
A prototype wearable device, tested in animal models, can continuously collect live cancer cells directly from a patient’s blood. Proposed as an alternative to...
Lessons from randomised controlled trials utilising SIRT in liver cancer
A recent session at CIRSE 2018 sought to go beyond the headline findings from a number of recent randomised controlled trials (RCTs) in interventional...
CT-guided radiofrequency thermal ablation a safe alternative to surgery for HCC patients
Percutaneous CT-guided radiofrequency thermal ablation is a safe and effective alternative treatment option in patients with pulmonary metastases from hepatocellular carcinoma (HCC) that cannot...
New augmented reality system lets IRs “literally see through the patient”
European Radiology Experimental has recently published a study on a new augmented reality system that is able to accurately guide interventional oncology procedures. A three-step...
OsteoCool RF ablation system gets expanded indication for palliative treatment of metastatic bone tumours
Medtronic has announced that the US FDA has cleared an expanded indication for the OsteoCool radiofrequency (RF) ablation system.
Originally cleared for use in the...
Interventional radiologists as the new “virus whisperers”
Oncolytic immunotherapy or virotherapy is not a threat to interventional oncology—on the contrary it is a “huge and urgent” opportunity, said Daniel Sze while...
Interventional oncologists tread new ground with focal control
As interventional oncologists embrace their growing clinical role and claim their place on multidisciplinary oncological teams, focal therapy is becoming an important part of their practice, according to Afshin Gangi, Strasbourg, France.
SIRFLOX trial results to be presented at ASCO
The SIRFLOX trial results will be presented by Peter Gibbs, co-principal investigator of the SIRFLOX trial, in the oral abstract session on gastrointestinal (colorectal) cancer at the American Society for Clinical Oncology (ASCO) annual meeting in Chicago, USA, on Saturday, 30 May 2015.
Cryoablation controls metastatic breast cancer with less pain and no major complications
Percutaneous cryoablation could potentially be used as a last line of defense to halt individual spots of remaining metastatic breast cancer by freezing and...
Riccardo Lencioni
As a former football referee, Riccardo Lencioni tells Interventional News readers how important it is to respect the rules —how important it is to...
